Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Anal Neoplasm”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT04534075
What this trial is testing

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of RectumMalignant Neoplasm of Anus+7 more
Sahlgrenska University Hospital 354
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Testing effectiveness (Phase 2)Study completedNCT04505553
What this trial is testing

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Who this might be right for
Appendix CarcinomaColon CarcinomaEsophageal Carcinoma+10 more
University of Washington 78
Testing effectiveness (Phase 2)Ended earlyNCT04066894
What this trial is testing

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Who this might be right for
Low Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT07059884
What this trial is testing

Distance-Based Exercise to Preserve Function and Prevent Disability

Who this might be right for
Localized Malignant Solid NeoplasmAnal CancerBladder (Urothelial, Transitional Cell) Cancer+16 more
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Looking for participantsNCT07407647
What this trial is testing

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Who this might be right for
Anal CarcinomaCervical CarcinomaMalignant Female Reproductive System Neoplasm+3 more
Ohio State University Comprehensive Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT01164722
What this trial is testing

Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia

Who this might be right for
Anal CancerNeoplasm of Uncertain Malignant PotentialNonneoplastic Condition+1 more
AIDS Malignancy Consortium 120
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableLooking for participantsNCT06630793
What this trial is testing

IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer

Who this might be right for
Malignant Neoplasm of Anal Canal
Tata Memorial Centre 108
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Not applicableStudy completedNCT05510908
What this trial is testing

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Who this might be right for
HIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more
AIDS Malignancy Consortium 460
Next Page